| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Prin Fin &Acct Officer | SVP, Chief Accounting Officer | Chief Accounting Officer
1 company
Wadhane Jitendra is a Prin Fin &Acct Officer at PYXS. Recent filings cover 3 purchases and 0 sales.
Our model assigns Wadhane Jitendra a strong insider score of 72/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +100.0%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27, 2023 | PYXS Pyxis Oncology, Inc. | Chief Accounting Officer | Buy | 2,500 | $1.87 | $4,675.00 | +1.1% | -5.4% | +102.2% | |
| Sep 25, 2023 | PYXS Pyxis Oncology, Inc. | Chief Accounting Officer | Buy | 5,000 | $1.77 | $8,850.00 | +2.3% | -2.2% | +102.2% | |
| Sep 22, 2023 | PYXS Pyxis Oncology, Inc. | Chief Accounting Officer | Buy | 2,500 | $1.74 | $4,349.25 | +1.2% | +4.4% | +130.6% |